Observational analysis shows decreased net carrier densities in β-Ga2O3, highlighting gallium vacancies' role in compensation.
Net carrier densities in highly Si-doped β-Ga2O3 decrease during thermal annealing as a function of temperature, time, and PO2 for both in situ and implant-doped films. The mechanism for this loss has been attributed to the formation of gallium vacancies (VGa3−), which act as compensating acceptors and form passivating defect complexes. Samples doped above 3 × 1019 cm−3, annealed at the same temperature and PO2, ultimately approach a similar net carrier density of 1–3 × 1019 cm−3 (for 950 °C and PO2 < 2 × 10−7 bar) independent of the starting dopant concentration or doping method. These highly doped samples, metastable under these conditions, generate VGa3− to reach the steady state |ND − NA|, determined by the Fermi level. An activation energy of 1.6 ± 0.2 eV was observed for the rate of net carrier loss in high concentration in situ doped films. Scanning transmission electron microscopy and electrical results for implanted samples show that dopant activation, lattice recovery, and compensation are all active within the first minutes of annealing. Understanding the metastability of higher doping levels and VGa3− formation allows for the development of mitigation strategies to achieve highly Si-doped β-Ga2O3 by implant (8 × 1019 cm−3 with >70 cm2/V s mobility), including using the minimum required anneal time to achieve lattice recovery and dopant activation, reducing vacancy formation. Compensation initially limited full activation of deeper implants to 1 × 1020 cm−3; by protecting the free surface with a SiO2 cap during annealing, the activation efficiency doubled, and the mobility increased by 30%, highlighting the importance of controlling VGa3− formation and compensation.
No takes yet. Share an insight, caveat, or question.
Gann et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: